Construction of artificial methemoglobin reduction systems in Hb vesicles

17Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

The hemoglobin vesicle (HbV) is a red cell substitute encapsulating purified concentrated Hb in a phospholipid vesicle. In order to suppress metHb formation for the long term maintenance of oxygen transporting capability in vivo, thiols (cysteine, Cys; homocysteine, Hcy) were studied as reductants of metHb. Hcy showed a suppressive effect on metHb formation, while Cys adversely accelerates metHb formation at the rate of twice the Hb solution without any reductants. The suppression of Cys-induced metHb formation by the addition of superoxide dismutase (SOD) and catalase indicated that Cys was easily oxidized by oxygen and simultaneously generated a large amount of active oxygens. The rate of metHb formation was influenced by PO2 and pH. Furthermore, the reducing systems (methylene blue (MB), NADH or ascorbic acid) were added to the outer aqueous phase of HbV, and the artificial reduction systems constructed through the bilayer membrane were evaluated.

Cite

CITATION STYLE

APA

Takeoka, S., Ohgushi, T., Sakai, H., Kose, T., Nishide, H., & Tsuchida, E. (1997). Construction of artificial methemoglobin reduction systems in Hb vesicles. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, 25(1–2), 31–41. https://doi.org/10.3109/10731199709118895

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free